Skip to main content
OpenTrials
Completed

NCT Number: NCT04970849

Survey Study About Endoscopy During COVID-19 Pandemic for IBD Doctors

Performance of diagnostic or therapeutic endoscopic procedures in inflammatory bowel disease (IBD) patients can be challenging during a viral pandemic; the main concerns being the safety and protection of patients and health care providers (HCP). The aim of this study is to identify endoscopic practice patterns and outcomes of IBD and coronavirus disease 19 (COVID-19) with a worldwide survey of HCP.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Inflammatory Bowel Diseases Digestive System Diseases Gastroenteritis Gastrointestinal Diseases Intestinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Second Affiliated Hospital Zhejiang University School of Medicine

Zhengzhou, Hangzhou, 310000, China

About this study

The 20-item survey questionnaire was sent to physician members of the American Society for Gastrointestinal Endoscopy Special Interest Group in Interventional IBD, Chinese IBD Society Endoscopy Interest Group, and the China Crohn's and Colitis Foundation. The data of the survey was collected and analyzed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Doctors who are involved in the endoscopic treatment of IBD patients;
  • The endoscopist reads and signs an informed consent online. -

Exclusion criteria

  • Doctors who are not involved in the endoscopic treatment of IBD patients
  • Doctors who need the help of an agent, a witness, or someone else who can not complete the questionnaire independently.
  • Other conditions that the researchers considered unsuitable for inclusion or influenced the participants'ability to complete the study.-

Treatment and study plan

observation

Other

IBD doctors who perform the endoscopy perform the questionnaire

Other names: endoscopy with no drug

Primary outcomes

  1. The influence of covid-19 pandemic on endoscopic practice by IBD endoscopist

    Time frame: 1 week

    The incidence of scheduled IBD endoscopies were postponed or cancelled due to the pandemic.

Secondary outcomes

  1. The incidence of COVID19 in IBD patients who underwent endoscopy

    Time frame: 1 week

    The percentage of IBD patients who underwent endoscopy since the outbreak was tested positive for COVID 19

Sponsors and collaborators

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Other

Registry information

Official study title

Patterns of Endoscopy During COVID-19 Pandemic: a Global Survey of Interventional Inflammatory Bowel Disease Practice

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Jul 21, 2021
Registry last updated
Jul 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.